[引用][C] Surgery in Motion

NB Dhar, TM Kessler, RD Mills, F Burkhard, UE Studer… - European Urology, 2007

Re: Risk of Prostate Cancer in Men Treated with 5α-Reductase Inhibitors—A Large Population-Based Prospective Study

MJ Resnick - Journal of Urology, 2019 - journals.lww.com
Editorial Comment: Stress urinary incontinence (SUI) remains a common public health
problem with a lifetime risk of surgery estimated at 14%. 1 Placement of a mid urethral sling …

1941 5 α REDUCTASE INHIBITORS AND RISK OF PROSTATE CANCER. NATION-WIDE, POPULATION-BASED CASE-CONTROL STUDY

D Robinson, H Garmo, A Bill-Axelson… - The Journal of …, 2013 - auajournals.org
METHODS A case-control study for men diagnosed with prostate cancer 2007 to 2009 within
Prostate Cancer data Base Sweden (PCBaSe) 2.0. was performed. Information from The …

Association of 5α-Reductase Inhibitor Use With Prostate Cancer–Specific Mortality

HV Stroomberg, K Brasso, A Røder - JAMA oncology, 2022 - jamanetwork.com
To the Editor We have read the cohort study by Björnebo et al1 on the association of 5α-
reductase inhibitors (5-ARIs) with prostate cancer oncological outcomes with great interest …

Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer

SS Taneja - Journal of Urology, 2019 - journals.lww.com
Editorial Comment: Anyone had water out of a plastic bottle today? The good news is that
single bottled water containers are packaged in polyethylene terephthalate (PET) plastic …

Association of 5α-Reductase Inhibitor Use With Prostate Cancer–Specific Mortality—Reply

L Björnebo, M Eklund, A Lantz - JAMA oncology, 2022 - jamanetwork.com
To the Editor We have read the cohort study by Björnebo et al1 on the association of 5α-
reductase inhibitors (5-ARIs) with prostate cancer oncological outcomes with great interest …

[引用][C] The motion: prevention of prostate cancer with a 5a-reductase inhibitor is feasible

CG Roehrborn, Y Lotan - Eur Urol, 2006 - Elsevier
Prostate cancer is the most common nondermatologic cancer in men and is the second
leading cause of cancer death among men in the United States, where it is estimated there …

5α-Reductase inhibitors and risk of prostate cancer death

T Bonde Miranda, H Garmo, P Stattin… - The Journal of …, 2020 - auajournals.org
Purpose: 5α-Reductase inhibitors reduced the risk of prostate cancer in 25% in 2
randomized trials but increased the risk of Gleason 8-10 at biopsy. One explanation is that …

Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study

D Robinson, H Garmo, A Bill-Axelson, L Mucci… - Bmj, 2013 - bmj.com
Objective To assess the association between 5α-reductase inhibitor (5-ARI) use in men with
lower urinary tract symptoms and prostate cancer risk. Design Nationwide, population based …

[引用][C] Surgery in Motion

C Barré, MJ Harris, R Postma, FH Schröder… - European Urology, 2007